Siemens and the incredible shrinking IPO
Siemens cuts down the size of its Healthineers spin-off partly thanks to market volatility, but still hopes to create a nimbler company.
Luck, strategy and FDA device approvals
Experience and high staff levels help companies negotiate FDA approval – but luck plays a part.
